Aim: To evaluate expression of proangiogenic matrix metalloproteinases (MMP) 2 and 9 at distinct intervals after verteporfin photodynamic therapy (PDT) in human choroidal neovascular membranes (CNV) secondary to age-related macular degeneration (AMD).
Methods: Retrospective review of an interventional case series of forty-nine patients who underwent removal of CNV. Twenty-six patients were treated with PDT 3 to 383 days prior to surgery. Twenty-three CNV without previous treatment were used as controls. CNV were stained for CD34, cytokeratin18, endostatin, MMP-2 and MMP-9 by immunohistochemistry.
Results: CNV without previous therapy disclosed MMP-2, MMP-9 in RPE-Bruch's membrane, vessels and stroma in different intensities. Three days after PDT, MMP-9 expression was significantly weaker in stroma (p=0.0019). Endostatin was significantly reduced in vessels (p=0.0005). At longer post-PDT intervals, a significant increase of MMP-9 in stroma (p=0.0373) and of endostatin in RPE-Bruch's membrane (p=0.02), vessels (p=0.005) and stroma (p=0.0007) were disclosed. No significant changes in MMP-2 expression were detected.
Conclusions: PDT induced an early, temporary decrease in MMP-9 and endostatin expression. At longer intervals, MMP-9 increase is possibly associated with the angiogenic process responsible for recurrence after PDT. MMP-9, however, acts as a double-edged sword by concomitant induction of endostatin, an endogenous inhibitor of angiogenesis.
- Age-related macular degeneration
- Choroidal neovascularization
- Matrix Metalloproteinases
- Verteporfin Photodynamic Therapy
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.